Palczewski K, Pulvermüller A, Buczylko J, Gutmann C, Hofmann K P
R.S. Dow Neurological Sciences Institute, Good Samaritan Hospital and Medical Center, Portland, OR 97209.
FEBS Lett. 1991 Dec 16;295(1-3):195-9. doi: 10.1016/0014-5793(91)81416-6.
Arrestin binds to phosphorylated rhodopsin in its light-activated form (metarhodopsin II), blocking thereby its interaction with the G-protein, transducin. In this study, we show that highly phosphorylated forms of inositol compete against the arrestin-rhodopsin interaction. Competition curves and direct binding assays with free arrestin consistently yield affinities in the micromolar range; for example, inositol 1,3,4,5-tetrakisphosphate (InP4) and inositol hexakisphosphate (InP6 bind to arrestin with dissociation constants of 12 microM and 5 microM, respectively. Only a small control amount of inositol phosphates is bound, when arrestin interacts with phosphorylated rhodopsin. This argues for a release of bound inositol phosphates by interaction with rhodopsin. Transducin, rhodopsin kinase, or cyclic GMP phosphodiesterase are not affected by inositol phosphates. These observations open a new way to purify arrestin and to inhibit its interaction with rhodopsin. Their physiological significance deserves further investigation.
抑制蛋白以其光激活形式(变视紫红质II)与磷酸化视紫红质结合,从而阻断其与G蛋白转导蛋白的相互作用。在本研究中,我们表明高磷酸化形式的肌醇可与抑制蛋白-视紫红质相互作用竞争。与游离抑制蛋白的竞争曲线和直接结合测定始终产生微摩尔范围内的亲和力;例如,1,3,4,5-四磷酸肌醇(InP4)和六磷酸肌醇(InP6)与抑制蛋白结合的解离常数分别为12微摩尔和5微摩尔。当抑制蛋白与磷酸化视紫红质相互作用时,只有少量对照量的肌醇磷酸被结合。这表明通过与视紫红质相互作用可释放结合的肌醇磷酸。转导蛋白、视紫红质激酶或环鸟苷酸磷酸二酯酶不受肌醇磷酸影响。这些观察结果为纯化抑制蛋白并抑制其与视紫红质的相互作用开辟了一条新途径。它们的生理意义值得进一步研究。